- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Plasma proteomic profiles may predict onset of dementia
A recent study published in the Nature Aging journal unveiled the promising use of proteomics in predicting the onset of dementia which offers hope for early detection and intervention.
The study analyzed data from the UK Biobank which included a total of 52,645 adults without dementia and tracked 1,417 incident cases over a span of 14.1 years. The focus of the research was on examining plasma proteins; out of 1,463 proteins studied, GFAP, NEFL, GDF15 and LTBP2 was found to be associated with incident all-cause dementia (ACD), Alzheimer’s disease (AD) and vascular dementia (VaD).
These proteins significantly ranked high in importance ordering and expressed promise in predicting dementia onset when combined with demographic factors. For instance, combining GFAP (or GDF15) with demographics produced highly accurate predictions for ACD (AUC = 0.891) and AD (AUC = 0.872) (or VaD (AUC = 0.912)), even over a 10-year period.
The participants with elevated levels of GFAP were found to be 2.32 times more risk to develop dementia by underlining its potential as a major biomarker for early detection. Also, GFAP and LTBP2 demonstrated high specificity for dementia prediction. Changes in GFAP and NEFL were observed at least a decade before dementia diagnosis which highlights the possibility of identifying high-risk individuals well in advance.
The findings of this study highlight the intricate mechanisms underlying dementia but also offer a hope for proactive screening and intervention strategies. Leveraging proteomics and understanding the predictive power of specific proteins could enable the healthcare professionals to identify individuals at risk of dementia long before symptoms manifest by improving the targeted interventions and outcomes.
Reference:
Guo, Y., You, J., Zhang, Y., Liu, W.-S., Huang, Y.-Y., Zhang, Y.-R., Zhang, W., Dong, Q., Feng, J.-F., Cheng, W., & Yu, J.-T. (2024). Plasma proteomic profiles predict future dementia in healthy adults. In Nature Aging. Springer Science and Business Media LLC. https://doi.org/10.1038/s43587-023-00565-0
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751